Form 4: Veraxa Biotech Holding CEO Buys Shares
Insider Transaction (Form 4)
Christoph Rudiger Antz, Chief Executive Officer and a Director of Veraxa Biotech Holding AG, purchased 5,000 shares of common stock on August 27, 2026 for $1.53 per share.
Summary
- Open-market purchase: acquired 5,000 Ordinary Shares at $1.53 ($7,650) on August 27, 2026; holds 5,000 after (Direct).
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a bullish signal: an insider made an open-market purchase of $7,650, committing personal capital to the stock.
Insider Transactions
Christoph Rudiger Antz — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-27 | Open-market purchase | Ordinary Shares | 5,000 | $2 | $7.7K | 5,000 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-27 | Open-market purchase (5,000 shares) |
Keywords
insider transaction, Form 4, VRXA, Veraxa Biotech AG - Post de-SPAC, bullish, Christoph Rudiger Antz
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.